Global Mirtazapine Market Outlook 2022

SKU ID :QYR-19747688 | Published Date: 21-Dec-2021 | No. of pages: 126
Mirtazapine ACTS on central presynaptic receptor 2 antagonist and enhances adrenergic nerve conduction.It regulates the function of 5-ht by interacting with central serotonin (5-ht2, 5-ht3) receptors.Both of mirtazapine's optically active enantiomers have antidepressant activity, with the levorotatory block of type 2 receptor and 5-ht2 receptor, and the right-handed block of 5-ht3 receptor.Mirtazapine has sedative effects, is well tolerated, has almost no anticholinergic effects, and its therapeutic dose has no effect on the cardiovascular system.

The global Mirtazapine market was valued at US$ million in 2020 and is expected to reach US$ million by the end of 2027, growing at a CAGR of % during 2021-2027.
This report focuses on Mirtazapine volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Mirtazapine market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Mirtazapine Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
15 Mg Tablets
30 Mg Tablets
45 Mg Tablets

Segment by Application
Depression
Insomnia
Weight Loss
Mood Swings
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Novartis
Organon
CIMA Labs.Inc.
Merck & Co
Teva
Mylan
Sun Pharmaceutical
IMPAX
Aurobindo Pharma
Zydus Pharmaceuticals
APOTEX
Harbin Sanlian Pharmaceutical
Shanxi Kangbao Biological Products
Huayu Pharmaceutical
Hangzhou Moshadong Pharmaceutical
Shanghai Xinyi Vientiane Pharmaceutical
  • PRICE
  • $2900
    $5800
    $4350
    Buy Now

Our Clients